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Background
The local accumulation of activated eosinophils in the
nasal mucosa is a feature of chronic polypous rhinosinusi-
tis (CPRS). However, the pathogenesis of chronic hypereo-
sinophilia in nasal polyps is still unknown. An increased
production of several chemoattractants, responsible for
guiding the inflammatory process, has been reported in
this disease. The aim of this study was to evaluate nasal
secretion levels of several chemokines and to correlate
those levels with clinical characteristics and degree of eosi-
nophilia in asthmatic and non-asthmatic patients with
polypous sinusitis.
Method
Fourteen non-atopic non-asthmatic patients with CPRS
and 14 CPRS patients with co-morbid atopic asthma were
recruited for this cross-sectional study. Fourteen healthy
subjects were included as controls. The concentrations of
GM-CSF, MCP-1, MCP-3, MIP-1alpha, MIP-1beta, and
RANTES in nasal secretions were measured using flow-
cytometric method. Eosinophil counts were performed by
percentage of differential granulocyte counts during cyto-
logical examination of scraped nasal mucosa obtained
from the inferior turbinate by rhinoprobe. Therefore, we
scored clinically each of the 28 nasal polyp patients
according to the nasal symptom score, endoscopic score,
and Lund-Mackay CT score.
Results
We found significantly higher concentrations of MCP-1
(p<0.0001), MCP-3 (p=0.018) and RANTES (p<0.0001)
in nasal fluid of asthmatic CPRS patients compared to
non-asthmatic. In non-asthmatic patients, we found
positive correlation between MIP-1alpha levels and
nasal symptom score, at the 0.01 level (p=0.01). There-
fore, the concentrations of RANTES were positive corre-
lated with nasal symptom score, nasal endoscopic score,
CT score, and eosinophil counts (p=0.01). On the other
hand, in asthmatic patients, the concentrations of MCP-
1 were associated with nasal symptom score, nasal endo-
scopic score, Lund-Mackay score, and percentage of
eosinophils (p=0.01). The concentration of RANTES in
asthmatic CPRS patients also correlate with all clinical
parameters, and with degree of eosinophilia (p=0.01).
Conclusion
CPRS in asthmatics is characterized by higher degree of
eosinophilic inflammation than in non-asthmatics.
RANTES and MCP-1 levels correlate well with clinical
severity of CPRS. The measurment of chemokines in nasal
secretions could be useful in evaluating the degree of sino-
nasal inflammation in nasal polyp patients.
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